Opus Genetics Inc

IRD USD0.0001
Create an alert
Sell$3.72
Buy$3.88
$0.22 (6.01%)
Last updated today at 05:36 UTC
Trade

Key metrics

Open$3.67
Previous close$3.66
Market cap$304.50m
P/E ratio-
Volume538,402
Dividend yield0.00%
EMS-

Company information

Opus Genetics, Inc. is a clinical-stage ophthalmic biotechnology company. The Company is engaged in developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other types of therapies for ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue83.20m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.